Background
New technologies offer the potential to assay a wide variety of biomarkers and immune state diagnostics that are informative about the physiological and immune status of a person and define the immunity markers that correlate with a state of protective immunity to particular diseases. Such information could be used as a decision-support tool for the design and evaluation of new or improved vaccines.